Judge Blocks Par Pharma's Generic Treximet
A Texas federal judge on Thursday barred Par Pharmaceutical Cos. Inc. from selling a generic version of Pozen Inc. migraine treatment Treximet in the U.S. until a patent infringement battle over...To view the full article, register now.
Already a subscriber? Click here to view full article